Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials

Background: Controversy exists regarding the optimal duration of the extended adjuvant endocrine treatment (ET) in patients with early-stage breast-cancer (eBC).We performed a systematic review and trial-level meta-analysis of all randomized clinical trials (RCTs) comparing a “limited-extended” adju...

Full description

Bibliographic Details

Main Authors:	Laura Pala, Tommaso De Pas, Eleonora Pagan, Isabella Sala, Chiara Catania, Emma Zattarin, Paolo Arnone, Massimo M. Grassi, Marco Colleoni, Antonio C. Wolff, Javier Cortes, Martine Piccart, Richard D. Gelber, Giuseppe Viale, Vincenzo Bagnardi, Fabio Conforti
Format:	Artigo
Language:	Inglês
Published:	Elsevier 2023-06-01
Series:	Breast
Subjects:	Early breast cancer Extended adjuvant endocrine therapy Disease nodal status meta-analysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S0960977623000358
Tags:	Add Tag No Tags, Be the first to tag this record!